Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Current Assets (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Current Assets for 12 consecutive years, with $21.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 42.76% year-over-year to $21.6 million, compared with a TTM value of $21.6 million through Sep 2025, down 42.76%, and an annual FY2024 reading of $34.6 million, down 35.88% over the prior year.
  • Current Assets was $21.6 million for Q3 2025 at Lisata Therapeutics, down from $24.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $65.3 million in Q1 2023 and bottomed at $21.6 million in Q3 2025.
  • Average Current Assets over 3 years is $43.2 million, with a median of $42.0 million recorded in 2024.
  • The sharpest move saw Current Assets dropped 27.17% in 2024, then tumbled 42.76% in 2025.
  • Year by year, Current Assets stood at $53.9 million in 2023, then crashed by 35.88% to $34.6 million in 2024, then plummeted by 37.6% to $21.6 million in 2025.
  • Business Quant data shows Current Assets for LSTA at $21.6 million in Q3 2025, $24.9 million in Q2 2025, and $28.6 million in Q1 2025.